Alliances
“Our goal is to successfully treat patients with severe inflammatory conditions and this is now possible through our alliance with Takeda,” said Denice Spero, president and chief business officer of ProThera.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 24, 2020.
Less than one month after Johnson & Johnson identified a lead vaccine candidate against COVID-19, the life sciences giant announced an agreement with Emergent BioSolutions to support the manufacturing needs for the potential medication.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 23, 2020.
Ken Pienta, acting chief medical officer of Cue Biopharma, said the researchers believe that CUE-101 may lead to enhanced anti-tumor activity in combination with Merck’s powerhouse checkpoint inhibitor.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 22, 2020.
The collaboration for development and commercialization combines Esperion’s knowledge in lipid management and Otsuka’s extensive cardiovascular drug advancement and marketing in Japan.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 21, 2020.
CEVEC Pharmaceuticals GmbH announced the signing of a license agreement with Evox Therapeutics, Ltd. for the development and commercialization of therapeutic exosomes using CEVEC’s proprietary CAP® technology.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 20, 2020.
PRESS RELEASES